Steve Schonfeld’s Terns Pharmaceuticals TERN Stock Holding History

Steve Schonfeld’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-50,000	Closed	-$2.64M	–	2998
2026 Q1	$2.64M	Buy	+50,000	New	+$2.05M	0.02%	708

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Steve Schonfeld's TERN Position: Q2 2026 in Review

Steve Schonfeld sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 165,725 shares — an estimated $8.74M sold.

Steve Schonfeld first reported a position in TERN in Q1 2023 and held it in 13 quarters. The position peaked at $30.5M in Q4 2025. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

Steve Schonfeld reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Steve Schonfeld sold 165,725 Terns Pharmaceuticals shares in Q2 2026, an estimated $8.74M.
Steve Schonfeld first reported a position in Terns Pharmaceuticals in Q1 2023 and held it in 13 quarters.
Steve Schonfeld's Terns Pharmaceuticals position peaked at $30.5M in Q4 2025.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.